Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic Variability.A Comparison Between Vildagliptin and Gliclazide MR

NCT01679899 is registered in ClinicalTrials.gov with Centro de Diabetes Curitiba Ltda as lead sponsor.

NCT NCT01679899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01679899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic Variability.A Comparison Between Vildagliptin and Gliclazide MR
Lead sponsor
Centro de Diabetes Curitiba Ltda
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2012
Completion date
October 31, 2015
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

menopause, osteopenia, osteoporosis, type 2 diabetes mellitus